Company Analysis Progyny, Inc.
1. Summary
Advantages
- The company's current efficiency (ROE=11.21%) is higher than the sector average (ROE=9.61%)
Disadvantages
- Price (18.76 $) is higher than fair price (9.14 $)
- Dividends (0%) are below the sector average (0.541%).
- The stock's return over the last year (-41.39%) is lower than the sector average (-12.5%).
- Current debt level 2.56% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Progyny, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 5.2% | 2.5% | 0.6% |
| 90 days | 43% | -17.8% | 2% |
| 1 year | -41.4% | -12.5% | 23.4% |
PGNY vs Sector: Progyny, Inc. has significantly underperformed the "Healthcare" sector by -28.89% over the past year.
PGNY vs Market: Progyny, Inc. has significantly underperformed the market by -64.79% over the past year.
Stable price: PGNY is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: PGNY with weekly volatility of -0.796% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (18.76 $) is higher than the fair price (9.14 $).
Price is higher than fair: The current price (18.76 $) is 51.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (61.54) is higher than that of the sector as a whole (48.77).
P/E vs Market: The company's P/E (61.54) is higher than that of the market as a whole (49.04).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (6.9) is higher than that of the sector as a whole (4.83).
P/BV vs Market: The company's P/BV (6.9) is higher than that of the market as a whole (3.17).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.51) is lower than that of the sector as a whole (33.77).
P/S vs Market: The company's P/S indicator (3.51) is lower than that of the market as a whole (10.24).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (58.01) is higher than that of the sector as a whole (-22.17).
EV/Ebitda vs Market: The company's EV/Ebitda (58.01) is higher than that of the market as a whole (28.32).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 6.97% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (6.97%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (4135.44%).
5.4. ROE
ROE vs Sector: The company's ROE (11.21%) is higher than that of the sector as a whole (9.61%).
ROE vs Market: The company's ROE (11.21%) is higher than that of the market as a whole (10.71%).
5.5. ROA
ROA vs Sector: The company's ROA (8.2%) is higher than that of the sector as a whole (0.3443%).
ROA vs Market: The company's ROA (8.2%) is higher than that of the market as a whole (6.47%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (23.18%) is higher than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (23.18%) is higher than that of the market as a whole (10.79%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.541%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 09.12.2024 | SEIDENBERG BETH C Director |
Purchase | 15.82 | 627 738 | 39 680 |
| 01.05.2024 | Sturmer Michael E PRESIDENT |
Sale | 31.95 | 144 254 | 4 515 |
| 27.03.2024 | Schlanger David J Executive Chairman |
Purchase | 3.95 | 281 524 | 71 272 |
| 27.03.2024 | Schlanger David J Executive Chairman |
Sale | 37.8 | 2 694 080 | 71 272 |
| 06.02.2024 | Sturmer Michael E PRESIDENT |
Sale | 40 | 90 400 | 2 260 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
